ZM1875A1 - Tablet formulation - Google Patents

Tablet formulation

Info

Publication number
ZM1875A1
ZM1875A1 ZM18/75A ZM1875A ZM1875A1 ZM 1875 A1 ZM1875 A1 ZM 1875A1 ZM 18/75 A ZM18/75 A ZM 18/75A ZM 1875 A ZM1875 A ZM 1875A ZM 1875 A1 ZM1875 A1 ZM 1875A1
Authority
ZM
Zambia
Prior art keywords
tablet formulation
formulation
tablet
Prior art date
Application number
ZM18/75A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZM1875(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZM1875A1 publication Critical patent/ZM1875A1/xx
Priority to ZM2976A priority Critical patent/ZM2976A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZM18/75A 1974-02-14 1975-02-13 Tablet formulation ZM1875A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZM2976A ZM2976A1 (en) 1974-02-14 1976-03-10 Tablet formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (1)

Publication Number Publication Date
ZM1875A1 true ZM1875A1 (en) 1975-12-22

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
ZM18/75A ZM1875A1 (en) 1974-02-14 1975-02-13 Tablet formulation

Country Status (32)

Country Link
JP (1) JPS5545043B2 (US08177716-20120515-C00003.png)
AT (1) AT344915B (US08177716-20120515-C00003.png)
AU (1) AU468465B2 (US08177716-20120515-C00003.png)
BE (1) BE825496A (US08177716-20120515-C00003.png)
CA (1) CA980688A (US08177716-20120515-C00003.png)
CH (1) CH618432A5 (US08177716-20120515-C00003.png)
CS (1) CS220306B2 (US08177716-20120515-C00003.png)
CY (1) CY1052A (US08177716-20120515-C00003.png)
DD (1) DD118228A5 (US08177716-20120515-C00003.png)
DE (1) DE2506099C2 (US08177716-20120515-C00003.png)
DK (1) DK143247C (US08177716-20120515-C00003.png)
DO (1) DOP1979002763A (US08177716-20120515-C00003.png)
ES (1) ES434688A1 (US08177716-20120515-C00003.png)
FI (1) FI62219C (US08177716-20120515-C00003.png)
FR (1) FR2260993B1 (US08177716-20120515-C00003.png)
GB (1) GB1499672A (US08177716-20120515-C00003.png)
GT (1) GT197960431A (US08177716-20120515-C00003.png)
HK (1) HK23980A (US08177716-20120515-C00003.png)
HU (1) HU171536B (US08177716-20120515-C00003.png)
IE (1) IE40599B1 (US08177716-20120515-C00003.png)
IL (1) IL46629A (US08177716-20120515-C00003.png)
IN (1) IN141019B (US08177716-20120515-C00003.png)
KE (1) KE3038A (US08177716-20120515-C00003.png)
LU (1) LU71835A1 (US08177716-20120515-C00003.png)
MC (1) MC1053A1 (US08177716-20120515-C00003.png)
MY (1) MY8100054A (US08177716-20120515-C00003.png)
NL (1) NL157501C (US08177716-20120515-C00003.png)
NO (1) NO146043C (US08177716-20120515-C00003.png)
PH (1) PH14575A (US08177716-20120515-C00003.png)
SE (1) SE427898B (US08177716-20120515-C00003.png)
ZA (1) ZA75930B (US08177716-20120515-C00003.png)
ZM (1) ZM1875A1 (US08177716-20120515-C00003.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
NO750467L (US08177716-20120515-C00003.png) 1975-08-15
AU7817075A (en) 1976-01-15
IE40599B1 (en) 1979-07-04
CY1052A (en) 1980-08-01
IN141019B (US08177716-20120515-C00003.png) 1977-01-08
AU468465B2 (en) 1976-01-15
HK23980A (en) 1980-05-09
DK52875A (US08177716-20120515-C00003.png) 1975-10-06
ZA75930B (en) 1976-01-28
GT197960431A (es) 1981-05-05
NO146043B (no) 1982-04-13
BE825496A (fr) 1975-05-29
SE7501595L (US08177716-20120515-C00003.png) 1975-08-15
NL7501680A (nl) 1975-08-18
DD118228A5 (US08177716-20120515-C00003.png) 1976-02-20
GB1499672A (en) 1978-02-01
SE427898B (sv) 1983-05-24
PH14575A (en) 1981-09-24
DK143247C (da) 1981-11-30
NO146043C (no) 1982-08-04
IE40599L (en) 1975-08-14
AT344915B (de) 1978-08-25
DE2506099A1 (de) 1975-08-21
CH618432A5 (en) 1980-07-31
ATA108475A (de) 1977-12-15
LU71835A1 (US08177716-20120515-C00003.png) 1975-06-24
MC1053A1 (fr) 1976-02-20
DOP1979002763A (es) 1987-06-18
CS220306B2 (en) 1983-03-25
KE3038A (en) 1980-04-25
FI750398A (US08177716-20120515-C00003.png) 1975-08-15
DK143247B (da) 1981-08-03
NL157501C (nl) 1981-07-16
ES434688A1 (es) 1977-04-01
DE2506099C2 (de) 1983-11-03
FR2260993A1 (US08177716-20120515-C00003.png) 1975-09-12
FR2260993B1 (US08177716-20120515-C00003.png) 1978-06-30
HU171536B (hu) 1978-01-28
IL46629A (en) 1977-07-31
FI62219C (fi) 1982-12-10
NL157501B (nl) 1978-08-15
IL46629A0 (en) 1975-05-22
CA980688A (en) 1975-12-30
JPS50116627A (US08177716-20120515-C00003.png) 1975-09-12
FI62219B (fi) 1982-08-31
MY8100054A (en) 1981-12-31
JPS5545043B2 (US08177716-20120515-C00003.png) 1980-11-15

Similar Documents

Publication Publication Date Title
SU1152510A3 (en) Stand
KE3052A (en) Pharmaceutical compositions
ZA74385B (en) Pharmaceutical compositions
ZA755998B (en) Pharmaceutical compositions
MY8100054A (en) Tablet formulation
MY8100372A (en) Pharmaceutical compositions
ZA76829B (en) Tablet formulation
KE2808A (en) Tablet formulation
NZ179502A (en) Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition
ZA755802B (en) Pharmaceutical compositions
HK73178A (en) Pharmaceutical compositions
PH12855A (en) Pharmaceutical compositions
JPS5120688A (en) Roran c jushinkyo fuirutasochi
ZM2976A1 (en) Tablet formulation
ZA755515B (en) Pharmaceutical formulations
ZA757295B (en) Hypolipemising drug
JPS5121274A (en) C gatapuresuseikeikakoteiisochi
JPS5132791A (en) Sefuarosuhorin c nosaishu seiseiho
IE39585B1 (en) Pharmaceutical compostitions
CA37950S (en) Ornamental tablet
IE43339L (en) Pharmaceutical composition
CS180187B1 (en) Pharmaceutical preparation
IE39123B1 (en) Pharmaceutical compositions
ZA744340B (en) Pharmaceutical compositions
ZA742246B (en) Pharmaceutical compositions